Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. 2007

Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
Department of Ophthalmology I, Eberhard-Karls University of Tuebingen, Schleichstrasse 12, 72076 Tuebingen, Germany. peter.szurman@med.uni-tuebingen.de

Epiretinal deposits of triamcinolone acetonide (TA) can be detrimental to retinal cells in vitro as several laboratory studies have shown. This contrasts with the good clinical experience of intravitreal TA use. We investigated the effect of TA crystals on retinal cells concerning the critical dose range, a potential cell recovery, the drug-tissue interaction and what protective biological factors could explain the discrepancy between in vivo and in vitro results. A human retinal pigment epithelium cell line (ARPE19) and transformed rat retinal ganglion cells (RGC5) were used. Purified TA crystals were either added directly on top of the cell cultures or on top of membrane filter inserts, basement membrane sheets or porcine vitreous with the cells growing underneath. To determine the number of live versus dead cells fluorescent stains were used. Proliferation and viability were measured using the MTT assay and the mean inhibitory dose (ID(50)) calculated with or without a filter. Cell recovery was measured after transient TA exposure (0.01-1 mg/ml) compared to continuous exposure after 7 days. To exclude a mere mechanical effect of epicellular deposits the TA crystals were replaced by glass pearls in a serum-free medium and the MTT toxicity assay was performed after 24 h. Without direct contact of TA crystals with the cells only a moderate decrease of mitochondrial activity was observed that fully recovered after transient exposure and showed a clinically safe ID(50) of 7.7 mg/ml. In contrast, direct exposure to even minute crystalline deposits for 7 days caused a rapid progressive and irreversible cell death being significant far below clinically used concentrations (ID(50) 0.058 mg/ml). Direct exposure to glass pearls did not show any loss of viability. Both basement membrane sheets and vitreous reliably prevented direct cytotoxicity to underlying retinal ganglion cells. Our findings suggest that irreversible TA cytotoxicity in a cell culture setting occurs earlier than previously assumed in the presence of even minute epicellular deposits. But in most clinical situations epiretinal TA deposits seem not to be harmful to ocular cells as protective biological factors may prevent close apposition of TA crystals to susceptible retinal cells. However, in eyes that have undergone vitrectomy with ILM peeling epimacular deposits could be critical.

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010857 Pigment Epithelium of Eye The layer of pigment-containing epithelial cells in the RETINA; the CILIARY BODY; and the IRIS in the eye. Eye Pigment Epithelium
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002461 Cell Line, Transformed Eukaryotic cell line obtained in a quiescent or stationary phase which undergoes conversion to a state of unregulated growth in culture, resembling an in vitro tumor. It occurs spontaneously or through interaction with viruses, oncogenes, radiation, or drugs/chemicals. Transformed Cell Line,Cell Lines, Transformed,Transformed Cell Lines
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents

Related Publications

Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
September 2006, Experimental eye research,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
June 2005, The British journal of ophthalmology,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
April 2008, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
September 2023, Retinal cases & brief reports,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
November 2011, Retina (Philadelphia, Pa.),
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
January 2013, Seminars in ophthalmology,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
September 2015, Journal of pharmaceutical sciences,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
September 2010, Journal of materials science. Materials in medicine,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
August 1985, Scandinavian journal of work, environment & health,
Peter Szurman, and Ana Sierra, and Radoslaw Kaczmarek, and Gesine B Jaissle, and Barbara Wallenfels-Thilo, and Salvatore Grisanti, and Matthias Lüke, and Karl U Bartz-Schmidt, and Martin S Spitzer
January 2006, Current eye research,
Copied contents to your clipboard!